Comanche Biopharma is a startup based in All, 1 tracked investor.
Comanche Biopharma is a company founded in 2026 headquartered in All. Brouky records 1 investor associated with the company.
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine to prevent or treat preterm preeclampsia, with a mission to make safe, evidence-based, and affordable therapies available globally.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.